Importance Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin is effective in
preventing recurrent strokes after minor ischemic stroke or transient ischemic attack (TIA) …

Importance Prior trials of dual antiplatelet therapy excluded patients with moderate ischemic
stroke. These patients were included in the Acute Stroke or Transient Ischaemic Attack …

Transient ischemic attack (TIA) and minor stroke account for 30% to 50% of all cerebral
ischemic events around the world. 1, 2 In the acute setting, mono-antiplatelet therapy …

Background and Purpose: Among patients with a transient ischemic attack or minor ischemic
strokes, those with ipsilateral atherosclerotic stenosis of cervicocranial vasculature have the …

Importance Reduction of subsequent disabling stroke is the main goal of preventive
treatment in the acute setting after transient ischemic attack (TIA) or minor ischemic stroke …

Background: Hypertension is a risk factor of poor stroke outcomes and associated with
antiplatelet resistance. This study aimed to explore the efficacy and safety of ticagrelor …

Rationale and aim Little is known about the safety and efficacy of the combination of
ticagrelor and aspirin in acute ischemic stroke. This study aimed to evaluate whether the …

Objective To test the hypothesis that ticagrelor plus aspirin is safe and superior to
clopidogrel plus aspirin for reducing high platelet reactivity at 90 days and stroke recurrence …

Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …

1478 Stroke May 2013 significant increase in prespecified bleeding events. In fact, despite
the more potent antithrombotic effect, the risk of intracranial hemorrhage or fatal stroke was …